Health and Happiness (H&H) International Holdings Limited (HKG:1112)
Hong Kong
· Delayed Price · Currency is HKD | Market Cap | 9.41B |
| Revenue (ttm) | 15.97B |
| Net Income (ttm) | 218.27M |
| Shares Out | 645.56M |
| EPS (ttm) | 0.34 |
| PE Ratio | 42.87 |
| Forward PE | 10.44 |
| Dividend | 0.35 (2.48%) |
| Ex-Dividend Date | May 19, 2026 |
| Volume | 2,974,581 |
| Average Volume | 2,735,851 |
| Open | 14.09 |
| Previous Close | 14.09 |
| Day's Range | 14.09 - 14.76 |
| 52-Week Range | 8.48 - 16.80 |
| Beta | 1.25 |
| RSI | 67.12 |
| Earnings Date | May 26, 2026 |
About HKG:1112
Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells pediatric nutrition, baby care, adult nutrition and care, and pet nutrition and care products in Mainland China, Australia, New Zealand, North America, and internationally. The company offers milk formulas for infants, children, and expectant and nursing mothers; probiotic and nutrition supplements in the form of sachets, capsules, gummies, and tablets for infants, children, and expectant mothers; and vitamins, herbal and mineral sup... [Read more]
News
Health and Happiness (H&H) International Holdings Earnings Call Transcript: Q1 2026
Q1 2026 saw 34.4% revenue growth, strong market share gains, and robust cash flow, driven by high-margin supplements and temporary demand surges. Guidance for 2026 is maintained, with continued focus on innovation, deleveraging, and channel expansion.
Full Year 2025 Health and Happiness (H&H) International Holdings Ltd Earnings Presentation ...
Full Year 2025 Health and Happiness (H&H) International Holdings Ltd Earnings Presentation (Chinese, English) Transcript
Health and Happiness (H&H) International Holdings Earnings Call Transcript: H2 2025
Revenue grew 10.3% year-on-year in 2025, with all segments returning to growth and strong cash flow supporting a reduced leverage ratio. Swisse achieved top market positions in China and Australia, while innovation and channel expansion drove performance across regions.
Health and Happiness (H&H) International Holdings Earnings Call Transcript: H1 2025
Revenue grew 4.9% year-over-year to over RMB 7 billion, with all segments achieving positive growth and EBITDA margin at 15.7%. Expansion markets and product innovation drove strong performance, while refinancing and channel optimization improved profitability and reduced leverage.
Health and Happiness (H&H) International Holdings Earnings Call Transcript: H2 2024
Nutritional supplements now drive 67.7% of revenue and 80% of EBITDA, offsetting IMF declines. 2024 saw strong cash flow, improved margins, and strategic refinancing, with a return to top-line growth and IMF recovery forecast for 2025.
Health and Happiness (H&H) International Holdings Earnings Call Transcript: H1 2024
Revenue declined 4.1% in H1 2024 due to infant formula weakness, but nutrition supplements grew to 66% of revenue. Adjusted EBITDA margin remained healthy at 17%, with improved inventory turnover and strong cash flow. Net leverage is targeted to reach 3x by year-end.